Trust Co. of Vermont Boosts Stock Holdings in Colgate-Palmolive Company $CL

Trust Co. of Vermont increased its position in Colgate-Palmolive Company (NYSE:CL) by 3.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 21,345 shares of the company’s stock after buying an additional 725 shares during the quarter. Trust Co. of Vermont’s holdings in Colgate-Palmolive were worth $1,940,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in CL. Pacific Point Advisors LLC raised its holdings in shares of Colgate-Palmolive by 5.1% in the 2nd quarter. Pacific Point Advisors LLC now owns 17,076 shares of the company’s stock worth $1,552,000 after purchasing an additional 829 shares during the period. Childress Capital Advisors LLC increased its position in Colgate-Palmolive by 54.1% during the 2nd quarter. Childress Capital Advisors LLC now owns 3,411 shares of the company’s stock worth $310,000 after purchasing an additional 1,197 shares in the last quarter. PFG Investments LLC increased its position in Colgate-Palmolive by 4.4% during the 2nd quarter. PFG Investments LLC now owns 23,119 shares of the company’s stock worth $2,101,000 after purchasing an additional 965 shares in the last quarter. Bennett Selby Investments LP lifted its position in Colgate-Palmolive by 41.8% during the second quarter. Bennett Selby Investments LP now owns 5,830 shares of the company’s stock valued at $530,000 after buying an additional 1,718 shares in the last quarter. Finally, HB Wealth Management LLC grew its stake in Colgate-Palmolive by 7.1% during the second quarter. HB Wealth Management LLC now owns 81,142 shares of the company’s stock worth $7,376,000 after buying an additional 5,370 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $78.95 on Thursday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a fifty-two week low of $78.76 and a fifty-two week high of $102.61. The business has a 50 day moving average price of $83.69 and a two-hundred day moving average price of $88.50. The firm has a market cap of $63.81 billion, a PE ratio of 22.18, a price-to-earnings-growth ratio of 4.16 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the prior year, the business posted $0.91 EPS. The business’s revenue was up 1.0% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CL. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research report on Thursday, September 25th. Citigroup reduced their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. UBS Group lowered their target price on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. Finally, Barclays reduced their price target on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $97.27.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.